PedAM

Pediatric Disease Annotations & Medicines

Disease	panic disorder
Phenotype	C0041696\|major depressive disorder
Sentences	15
PubMedID- 20663271	A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
PubMedID- 23037667	Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naive, major depressive disorder with panic disorder patients.
PubMedID- 22137181	Objective: we designed this study to investigate the changes of regional homogeneity (reho) after a 6-week duloxetine therapy in first-episode drug-naive major depressive disorder with panic disorder (femddpd) patients.
PubMedID- 23037661	Increased anterior cingulate regional homogeneity after duloxetine therapy in first-episode, drug-naive, major depressive disorder with panic disorder patients: a case series.
PubMedID- 21926486	Milnacipran in panic disorder with agoraphobia and major depressive disorder: a case report.
PubMedID- 19833160	Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
PubMedID- 21677224	Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.
PubMedID- 20599363	First episode drug-naive major depressive disorder with panic disorder: gray matter deficits in limbic and default network structures.
PubMedID- 20075662	Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.
PubMedID- 23133615	(2011) demonstrated that first-episode drug-naïve major depressive disorder with panic disorder patients displayed increased reho in the medial frontal cortex after short-term duloxetine therapy [45].
PubMedID- 21948903	Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients.
PubMedID- 23861180	Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after ssri treatment in the star*d trial.
PubMedID- 24860227	She was diagnosed has having panic disorder with major depressive disorder.
PubMedID- 24509652	Structural alterations of the putamen, hippocampus, and thalamus might represent the structural pathophysiology of major depressive disorder comorbid with panic disorder.
PubMedID- 22303519	The search terms were bipolar disorder and major depressive disorder, cross-referenced with anxiety disorders/symptoms, panic disorder, agoraphobia, generalized anxiety disorder, social phobia, obsessive-compulsive disorder, and posttraumatic stress disorder.

Page: 1